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The patients were divided into two groups. Group 1 comprised 30 patients who had not received antibiotic treatment prior to admission, whilst group 2 comprised 23 patients who had been treated with antibiotics.
The authors reported that the most frequent underlying diseases were chronic obstructive pulmonary disease (COPD) (32%), congestive heart failure, and alcoholism (13.2%). The authors also stated that there was no significant difference in frequency of co-existing illnesses between the groups. In relation to the inclusion/exclusion criteria, it was reported that pneumonia was defined as any acute septic episode with respiratory symptoms and a new progressive infiltrate on chest x-rays. Community acquired infection was defined as an infection occurring before or within 48 hours after admission in patients who had not been hospitalised during the proceeding two weeks. Moderate CAP was defined as an infection requiring hospitalisation in a respiratory unit but not in an intensive care unit.
The authors reported that patients with a clinical history suggestive of aspiration, a severe pneumonia requiring an intensive care unit, an immunosuppressive illness, or who were being treated with immunosuppressive drugs, were excluded from the study.
Study design
The evaluation used a prospective observational study design, and was carried out in a single centre, the Centre Hospitalier Universitaire Sud, in Amiens, France. The duration of follow-up was 15 days after hospitalisation. The patients were not randomised to blood cultures or no blood cultures. The study did not include a comparator group of patients who did not have blood cultures.
Analysis of effectiveness
All patients included in the study were included in the reported analysis, which suggests an intention to treat analysis. The primary outcomes used in the economic analysis were: the number of blood cultures, the number of blood cultures per patient, the number of patients with bacteraemia, and the number of positive blood cultures. An explicit comparator group was not reported.
Effectiveness results
The results were as follows: 
Clinical conclusions
The authors concluded that the results of microbiological blood cultures did not influence hospital antibiotic treatment for patients with moderate CAP. The authors also concluded that the results showed a reduced clinical utility of blood cultures in patients hospitalised for moderate CAP, and who had received an antibiotic treatment prior to admission.
